Metraipolis › archive › dc_2ed7580b89f5
Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial — Europe PMC PMID:41188524
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41188524
- DOI
- 10.1038/s41591-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T19:37:57.404Z
- SHA-256 of the archived text
80644a01c9fb0c3d448d9f0ef57ff36b8bb405c51010eaddbd583e8bf92eb10d- Stable URL of this page
https://metraipolis.com/documento/dc_2ed7580b89f5
How to cite
Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial — Europe PMC PMID:41188524 — Europe PMC (en), https://europepmc.org/article/MED/41188524 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ed7580b89f5 (Metraipolis archive dc_2ed7580b89f5, sha256 80644a01c9fb0c3d448d9f0ef57ff36b8bb405c51010eaddbd583e8bf92eb10d)
BibTeX
@misc{dc2ed7580b89f5,
title = {Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial — Europe PMC PMID:41188524},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41188524},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ed7580b89f5; sha256 80644a01c9fb0c3d448d9f0ef57ff36b8bb405c51010eaddbd583e8bf92eb10d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41188524. Agents can read the archived copy with the MCP tool read_document.